<?xml version="1.0" encoding="UTF-8"?>
<p>Since the first detection of the novel coronavirus-2019 (SARS-CoV-2) in the Wuhan City of China in December 2019, researchers from all over the world are investigating and collaborating for the determination of the virus structure and its mode of infection in order to find a treatment against COVID-19 and a vaccine for a longer protection. The experience from previous virus epidemics indicate that cocktail of neutralizing antibodies are promising for a stronger virus neutralization. Therefore, it is important to discover several antibodies able to block the virus, and this variety can be achieved by the use of various antibody development technologies.</p>
